mRNA Expression Differences of uPA, uPAR in Eutopic Endometrium of Advanced Stage Endometriosis Patients |
Hur, Sung Eun
(Department of Obstetrics and Gynecology, Konyang University, School of Medicine)
Lee, Ji Young (Department of Obstetrics and Gynecology, College of Medicine, Konkuk University) Lee, Woon Jung (Department of Obstetrics and Gynecology, College of Medicine, Ewha Womans University) Chung, Hye-Sung (Department of Obstetrics and Gynecology, College of Medicine, Ewha Womans University) Chung, Hye Won (Department of Obstetrics and Gynecology, College of Medicine, Ewha Womans University) |
1 | Berkkanoglu M, Arici A. Immunology and endometriosis. Am J Reprod Immunol 2003; 50: 48-59 DOI |
2 | American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril 1997; 67: 817-21 DOI ScienceOn |
3 | Gilabert-Estelles J, Estelles A, Gilabert J, Castello R, Espana F, Falco C, et al. Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod 2003; 18: 1516-22 DOI ScienceOn |
4 | Bruse C, Bergqvist A, Carlstrom K, Fianu-Jonasson A, Lecander I, Astedt B. Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women. Fertil Steril 1998; 70: 821-6 DOI ScienceOn |
5 | Sillem M, Prifti S, Monga B, Buvari P, Shamia U, Runnebaum B. Soluble urokinase-type plasminogen activator receptor is over-expressed in uterine endometrium from women with endometriosis. Mol Hum Reprod 1997; 3: 1101-5 DOI ScienceOn |
6 | Chung HW, Wen Y, Chun SH, Nezhat C, Woo BH, Lake Polan M. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness. Fertil Steril 2001; 75: 152-9 DOI ScienceOn |
7 | Kobayashi H. Invasive capacity of heterotopic endometrium. Gynecol Obstet Invest 2000; 50: 26-32 DOI ScienceOn |
8 | Pyke C, Eriksen J, Solberg H, Nielsen BS, Kristensen P, Lund LR, et al. An alternatively spliced variant of mRNA for the human receptor for urokinase plasminogen activator. FEBS Lett 1993; 326: 69-74 DOI |
9 | Kennedy S. Is there a genetic basis to endometriosis- Semin Reprod Endocrinol 1997; 15: 309-18 DOI |
10 | Witz CA, Thomas MR, Montoya-Rodriguez IA, Nair AS, Centonze VE, Schenken RS. Short-term culture of peritoneum explants confirms attachment of endometrium to intact peritoneal mesothelium. Fertil Steril 2001; 75: 385-90 DOI ScienceOn |
11 | Shen X, Minoura H, Yoshida T, Toyoda NNy T, Leonardsson G, Peng XR. Changes in ovarian expression of tissue-type plasminogen activator and plasminogen activator inhibitor type-I messenger ribonucleic acids during ovulation in rat. Endocr J 1997; 44: 341-8 DOI ScienceOn |
12 | Chung HW, Lee JY, Moon HS, Hur SE, Park MH, Wen Y, et al. Matrix metalloproteinase-2, membranous type I matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 2002; 78: 787-95 DOI ScienceOn |
13 | Loskutoff OJ, Sawdey M, Mimuro J. Type 1 plasminogen activator inhibitor. Prog Hemost Thromb 1989; 9: 87-115 |
14 | Simpson JL, Elias S, Malinak LR, Buttram VC Jr. Heritable aspects of endometriosis. I. Genetic studies. Am J Obstet Gynecol 1980; 137: 327-31 DOI |
15 | Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 1927; 14: 422-69 DOI |
16 | Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975; 122: 262-3 DOI |
17 | Sappino AP, Huarte J, Belin D, Vassalli JD. Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos. J Cell Biol 1989; 109: 2471-9 DOI ScienceOn |
18 | Krunithof EKO. Plasminogen activator inhibitors-a review. Enzyme 1988; 40: 113-21 DOI |